FGFR2 and infantile convulsions and choreoathetosis: Consequently, for iCCA patients, clinical guidelines routinely recommend the use of next-generation sequencing (NGS) or fluorescence in situ hybridization (FISH) to identify individuals eligible for FGFR2-targeted therapy.